Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection.

Dolganiuc A, Chang S, Kodys K, Mandrekar P, Bakis G, Cormier M, Szabo G.

J Immunol. 2006 Nov 15;177(10):6758-68.

2.

Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profile.

Cecere A, Marotta F, Vangieri B, Tancredi L, Gattoni A.

Panminerva Med. 2004 Sep;46(3):171-87. Review.

PMID:
15510086
3.

The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.

Salem ML, El-Demellawy M, El-Azm AR.

Cell Immunol. 2010;262(2):96-104. doi: 10.1016/j.cellimm.2010.03.002. Epub 2010 Mar 6. Review.

PMID:
20338549
4.

Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.

Gonzalez VD, Landay AL, Sandberg JK.

Clin Immunol. 2010 Apr;135(1):12-25. doi: 10.1016/j.clim.2009.12.005. Epub 2010 Jan 25. Review.

PMID:
20100670
5.

The molecular basis of HCV-mediated immune dysregulation.

Eisen-Vandervelde AL, Yao ZQ, Hahn YS.

Clin Immunol. 2004 Apr;111(1):16-21. Review.

PMID:
15093547
6.

Involvement of plasmacytoid dendritic cells in human diseases.

Jahnsen FL, Farkas L, Lund-Johansen F, Brandtzaeg P.

Hum Immunol. 2002 Dec;63(12):1201-5. Review.

PMID:
12480264
7.
8.

Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity.

Rönnblom L, Eloranta ML, Alm GV.

Autoimmunity. 2003 Dec;36(8):463-72. Review.

PMID:
14984023
9.

Role for plasmacytoid dendritic cells in anti-HIV innate immunity.

Müller-Trutwin M, Hosmalin A.

Immunol Cell Biol. 2005 Oct;83(5):578-83. Review.

PMID:
16174110
10.

Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature.

Beuthien W, Mellinghoff HU, Kempis Jv.

Clin Rheumatol. 2005 Sep;24(5):507-15. Epub 2005 Jun 30. Review.

PMID:
15988558
11.

The affect of chronic hepatitis C infection on dendritic cell function: a summary of the experimental evidence.

Ryan EJ, O'Farrelly C.

J Viral Hepat. 2011 Sep;18(9):601-7. doi: 10.1111/j.1365-2893.2011.01453.x. Epub 2011 Mar 14. Review.

PMID:
21794024
12.

HCV and innate immunity.

Ebihara T, Matsumoto M, Seya T.

Uirusu. 2008 Jun;58(1):19-26. Review.

13.

The natural interferon-alpha producing cells in systemic lupus erythematosus.

Rönnblom L, Alm GV.

Hum Immunol. 2002 Dec;63(12):1181-93. Review.

PMID:
12480262
14.

[Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells].

Rodrigue-Gervais IG, Lamarre D.

Med Sci (Paris). 2010 Oct;26(10):869-74. doi: 10.1051/medsci/20102610869. Review. French.

15.

Neutralising antibody, CTL and dendritic cell responses to hepatitis C virus: a preventative vaccine strategy.

Torresi J, Bharadwaj M, Jackson DC, Gowans EJ.

Curr Drug Targets. 2004 Jan;5(1):41-56. Review.

PMID:
14738217
16.

Plasmacytoid dendritic cells: physiologic roles and pathologic states.

Jegalian AG, Facchetti F, Jaffe ES.

Adv Anat Pathol. 2009 Nov;16(6):392-404. doi: 10.1097/PAP.0b013e3181bb6bc2. Review.

PMID:
19851130
17.

Apoptosis in hepatitis C.

Kountouras J, Zavos C, Chatzopoulos D.

J Viral Hepat. 2003 Sep;10(5):335-42. Review.

PMID:
12969183
18.

Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection.

Caradonna L, Mastronardi ML, Magrone T, Cozzolongo R, Cuppone R, Manghisi OG, Caccavo D, Pellegrino NM, Amoroso A, Jirillo E, Amati L.

Curr Pharm Des. 2002;8(11):995-1005. Review.

PMID:
11945146
19.

Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?

Pachiadakis I, Pollara G, Chain BM, Naoumov NV.

Lancet Infect Dis. 2005 May;5(5):296-304. Review.

PMID:
15854885

Supplemental Content

Support Center